Trial · NCT02952586
Participant flow44
How many started, completed or left each group, period by period.
1 to 20 of 44
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Lead-In Phase (7 Days) | STARTED | Avelumab + Standard of Care Chemotherapy (SOC CRT) | 350 | |
| Lead-In Phase (7 Days) | STARTED | Placebo + SOC CRT | 347 | |
| Lead-In Phase (7 Days) | Safety Analysis Set | Avelumab + Standard of Care Chemotherapy (SOC CRT) | 348 | |
| Lead-In Phase (7 Days) | Safety Analysis Set | Placebo + SOC CRT | 344 | |
| Lead-In Phase (7 Days) | COMPLETED | Avelumab + Standard of Care Chemotherapy (SOC CRT) | 345 | |
| Lead-In Phase (7 Days) | COMPLETED | Placebo + SOC CRT | 343 | |
| Lead-In Phase (7 Days) | NOT COMPLETED | Avelumab + Standard of Care Chemotherapy (SOC CRT) | 5 | |
| Lead-In Phase (7 Days) | NOT COMPLETED | Placebo + SOC CRT | 4 | |
| CRT for Avelumab or Placebo (63 Days) | STARTED | Avelumab + Standard of Care Chemotherapy (SOC CRT) | 345 | |
| CRT for Avelumab or Placebo (63 Days) | STARTED | Placebo + SOC CRT | 340 | |
| CRT for Avelumab or Placebo (63 Days) | COMPLETED | Avelumab + Standard of Care Chemotherapy (SOC CRT) | 312 | |
| CRT for Avelumab or Placebo (63 Days) | COMPLETED | Placebo + SOC CRT | 313 | |
| CRT for Avelumab or Placebo (63 Days) | NOT COMPLETED | Avelumab + Standard of Care Chemotherapy (SOC CRT) | 33 | |
| CRT for Avelumab or Placebo (63 Days) | NOT COMPLETED | Placebo + SOC CRT | 27 | |
| CRT for Cisplatin (63 Days) | STARTED | Avelumab + Standard of Care Chemotherapy (SOC CRT) | 345 | |
| CRT for Cisplatin (63 Days) | STARTED | Placebo + SOC CRT | 340 | |
| CRT for Cisplatin (63 Days) | COMPLETED | Avelumab + Standard of Care Chemotherapy (SOC CRT) | 234 | |
| CRT for Cisplatin (63 Days) | COMPLETED | Placebo + SOC CRT | 236 | |
| CRT for Cisplatin (63 Days) | NOT COMPLETED | Avelumab + Standard of Care Chemotherapy (SOC CRT) | 111 | |
| CRT for Cisplatin (63 Days) | NOT COMPLETED | Placebo + SOC CRT | 104 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02952586/flow